| ¿µ¹® | medical record | ÇÑ±Û | Àǹ«±â·Ï |
|---|---|---|---|
| ¼³¸í | Àǹ«±â·ÏÀº ¹ýÀûÀ¸·Î º¸È£¸¦ ¹Þ°Ô µÇ¾î ÀÖÀ¸¸ç, ƯÈ÷ Áø·á±â·ÏºÎ¿Í ¼ö¼ú±â·ÏºÎ´Â 10³â°£ º¸Á¸À» Çϵµ·Ï ¹ý¿¡ ¸í½ÃµÇ¾î ÀÖ´Ù. ¶ÇÇÑ ¹ý¿¡ ÀÇÇÑ °æ¿ì°¡ ¾Æ´Ï°í¼´Â ŸÀο¡°Ô º¸¿©ÁöÁö ¾Êµµ·Ï µÇ¾î ÀÖ´Ù. ±×·¯³ª, ȯÀÚÀÇ Áø·á¸¦ À§ÇÏ¿©, ´Ù¸¥ ÀÇ»çÀÇ ¿ä±¸°¡ ÀÖÀ¸¸é, À̸¦ º¸¿©ÁÖµµ·Ï µÇ¾î ÀÖ´Ù. |
||
| ¿µ¹® | medical examination | ÇÑ±Û | ÀÇÇÐÀû °Ë»ç |
|---|---|---|---|
| ¼³¸í | 1. °Ç°ÀÇ À¯Áö¿Í ÁõÁø, º´ÀÇ Á¶±â ¹ß°ßÀ̳ª ¿¹¹æ µûÀ§¸¦ À§Çؼ ½É½ÅÀÇ »óŸ¦ °Ë»çÇÏ´Â ÀÏ. 2. Àǻ糪 Ä¡°úÀǻ簡 ÀÚ°¢Àû-Ÿ°¢ÀûÀ¸·Î °Ç°ÇÑ »ç¶÷¿¡ ´ëÇÏ¿© ±× °Ç° »óŸ¦ ÁøÂûÇÏ´Â ÀÏ. °Ç°À» À¯ÁöÇϱâ À§Çؼ´Â Áúº´ÀÇ Áø´Ü°ú Ä¡·á°¡ ÇÊ¿äÇÏÁö¸¸, Ä¡·á¿¡ À־µ ÀÚ°¢Áõ»óÀ̳ª Ÿ°¢Áõ»óÀÌ ÀÖ°í ³ª¼ ¼ÕÀ» ¾²´Ù º¸¸é ÀÌ¹Ì ¶§°¡ ´ÊÀ» °æ¿ì°¡ ¸¹À¸¹Ç·Î, ¹ßº´ Ãʱ⿡ Á¶±âÁø´ÜÀ» ÇÔÀ¸·Î½á °Ç°»ýȰÀ» Àû±ØÀûÀ¸·Î ¼³°èÇÏ·Á´Â µ¥¿¡ ÀÇÀǰ¡ ÀÖ´Â °ÍÀÌ´Ù. °Ç°Áø´ÜÀ» Å©°Ô ³ª´©¸é, °³ÀÎÀû °Ç°À¯Áö¸¦ À§ÇÑ °Í°ú, ±¹¹Î ÀüüÀÇ °Ç°À¯Áö¸¦ À§ÇÏ¿© ÇàÁ¤ÀûÀ¸·Î ƯÁ¤ÇÑ ´ë»óÀÚ¿¡°Ô Àǹ«ÀûÀ¸·Î ÇÏ´Â °ÍÀÌ Àִµ¥, ÈÄÀÚÀÇ °æ¿ì¸¦ ¡®Á¤±â°Ç°Áø´Ü¡¯À̶ó°í ÇÑ´Ù. ±Ù·Îº¸°Ç°ü¸®±ÔÁ¤¿¡´Â À§»ý»ó À¯ÇØÇÑ Á÷ÀåÀÇ Á¾¾÷¿øÀº ¿¬2ȸ ÀÌ»óÀÇ °Ç°Áø´ÜÀ» ÇÊ¿ä·Î Çϰí ÀÖÀ¸¸ç, ±× ¹ÛÀÇ Á÷Àå¿¡¼´Â ¿¬1ȸ ÀÌ»óÀ¸·Î ±ÔÁ¤Çϰí ÀÖ´Ù. Çб³º¸°Ç¹ý¿¡¼´Â ¸Å³â Çлý°ú ±³Á÷¿øÀÇ ½Åü°Ë»ç¸¦ ÇÏ°Ô µÇ¾î ÀÖ°í, °áÇÙ¿¹¹æ¹ý¿¡¼´Â ¸ðµç ±¹¹ÎÀº ¿¬1ȸ ÀÌ»ó °áÇÙ¿¡ °üÇÑ °Ç°Áø´ÜÀ» ¹Þµµ·Ï µÇ¾î ÀÖÀ¸¸ç, ¸ðÀÚº¸°Ç¹ý¿¡¼´Â ÀÓ½ÅºÎ¿Í ¿µÀ¯¾Æ¿¡ ´ëÇÑ °Ç°Áø´ÜÀ» ±ÔÁ¤Çϰí ÀÖ´Ù. ÀÌ ¹Û¿¡ Á¢°´¾÷¼Ò¿¡¼µµ Àü¿°º´-ÇǺκ´¿¡ °üÇÑ °Ç°Áø´ÜÀ» ¹Þ¾Æ¾ß ÇÑ´Ù´Â ±ÔÁ¤ÀÌ ¾÷Á¾º°·Î Á¤ÇØÁ® ÀÖ´Ù. |
||
| ¿µ¹® | electronic medical record(EMR) | ÇÑ±Û | ÀüÀÚÀǹ«±â·Ï |
|---|---|---|---|
| ¼³¸í | Àǻ簡 Á¾ÀÌ ´ë½Å ÄÄÇ»ÅÍ¿¡ Á÷Á¢ ȯÀÚÀÇ ÀÓ»óÁ¤º¸¸¦ ÀÔ·ÂÇϸé À̸¦ µ¥ÀÌÅͺ£À̽ºÈÇÏ¿© »õ·Î¿î Á¤º¸·Î °¡°ø-»ý¼ºÇÏ´Â ÀÇ·áÁ¤º¸½Ã½ºÅÛ. ȯÀÚÀÇ Áø·á±â·ÏÀ» ã¾Æ Áø·á½Ç¿¡ Àü´ÞÇÏ°í ´Ù½Ã Ã³¹æÀüÀ» ¹Þ¾Æ Á¶Á¦ÇÏ´Â ÀÏ·ÃÀÇ °úÁ¤ÀÌ ³×Æ®¿öÅ©·Î 󸮵ŠȯÀÚ´ë±â½Ã°£ÀÌ ´ëÆø ÁÙ°í, º°µµÀÇ Áø·á±â·Ï½ÇÀÌ ºÒÇÊ¿äÇÏ´Ù. |
||
| BMJ | bones, muscles, joints; British Medical Journal |
|---|---|
| JAMA | Journal of the American Medical Association |
| JAMIA | Journal of the American Medical Informatics Association |
| MS | Maffuci syndrome; maladjustment score; mandibular series; Marfan syndrome; Marie-Strumpell [syndrome... |
| BAN | British Approved Name; British Association of Neurologists |
| JAMA | Journal of the American Medical Association |
|---|---|
| BMRC | British Medical Research Council |
| NEJM | New England Journal of Medicine |
| B.C. | British Columbia |
| BHS | British Hypertension Society |
| journal article | The predominant publication type for articles and other items indexed for nlm databases. (12 Dec 1998) |
|---|---|
| British anti-Lewisite | <chemical> 2,3-dimercapto-1-propanol. An anti-gas warfare agent that is effective against lewisite (dichloro(2-chlorovinyl)arsine). It acts as a chelating agent and is used in the treatment of arsenic, gold, and other heavy metal poisoning. Pharmacological action: antidotes, chelating agents. Chemical name: 1-Propanol, 2,3-dimercapto- (12 Dec 1998) |
| british columbia | A province of canada on the pacific coast. Its capital is victoria. The name given in 1858 derives from the columbia river which was named by the american captain robert gray for his ship columbia which in turn was named for columbus. (12 Dec 1998) |
| British gum | A form of dextrin. (05 Mar 2000) |
| British Thermal Unit | <unit> Unit of energy needed to raise one pound of water by one degree fahrenheit. It is equal to 252 calories or 1055 Joules. Acronym: BTU (13 Nov 1997) |
| French-American-British classification | <haematology> The classification of acute myeloid leukaemia on the basis of bone marrow and peripheral blood features. M0: Acute myeloid leukaemia with minimal evidence of myeloid differentiation. M1: Acute myeloblastic leukaemia. M2: Acute myeloblastic leukaemia with differentiation. M3: Acute promyelocytic leukaemia. M4: Acute myelomonocytic leukaemia. M5: Acute monocytic leukaemia. M6: Acute erythroleukaemia. M7: Acute megakaryocytic leukaemia. Acronym: FAB (07 Apr 1998) |
| academic medical centres | Medical complexes consisting of medical school, hospitals, clinics, libraries, administrative facilities, etc. (12 Dec 1998) |
| advance medical directives | Advance directives preserve the person's right to accept or reject a course of medical treatment even after that person becomes mentally or physically incapacitated to the point of being unable to communicate those wishes. There ared two basic types of advance directives: (1) a living will, in which the person outlines specific treatment guidelines that are to be followed by health care providers; (2) a health care proxy (also called a power of attorney for healthcare decision making) in which the person designates a trusted individual to make medical decisions in the event that he or she becomes too incapacitated to make such decisions. Advance directive requirements vary greatly from one jurisdiction to another and should therefore be drawn up in consultation with an attorney who is familiar with the laws of the particular jurisdiction. (This entry is based upon material from the National MS Society). (12 Mar 2000) |
| american medical association | Professional society representing the field of medicine. (12 Dec 1998) |
| genetics, medical | A field of human genetics which entails the reliable prediction of certain human disorders as a function of the lineage and/or genetic makeup of any two parents or potential parents. (12 Dec 1998) |
| reference books, medical | Books in the field of medicine intended primarily for consultation. (12 Dec 1998) |
| regional medical programs | Coordination of activities and programs among health care institutions within defined geographic areas for the purpose of improving delivery and quality of medical care to the patients. These programs are mandated under u.s. Public law 89-239. (12 Dec 1998) |
| medical | Pertaining to medicine or to the treatment of diseases, pertaining to medicine as opposed to surgery. (18 Nov 1997) |
| medical anatomy | Anatomy in its bearing upon the diagnosis and treatment of diseases. (05 Mar 2000) |
| medical assistance | Financing of medical care provided to public assistance recipients. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|